表紙
市場調查報告書

結合型疫苗的全球市場的分析與預測

Global Conjugate Vaccine Market Research and Forecast, 2018-2023

出版商 Orion Market Research Pvt Ltd 商品編碼 658991
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
結合型疫苗的全球市場的分析與預測 Global Conjugate Vaccine Market Research and Forecast, 2018-2023
出版日期: 2018年06月26日內容資訊: 英文
簡介

本報告提供全球結合型疫苗 (結合物疫苗,共軛疫苗) 市場現況與展望相關分析,提供疾病概要和市場基本結構,外部的宏觀·微觀性影響,主要的促進·阻礙因素,各產品種類·各疾病·患者類別·病原體類別·各地區的市場趨勢預測 (今後7年份),最新的市場競爭情形,主要企業簡介等調查。

第1章 分析概要

第2章 市場概要與考察

  • 定義
  • 分析師的見解與目前市場趨勢
    • 分析的要點
    • 建議
    • 結論
  • 全球各國的法規情形 (美國,歐洲,中國,印度等)
  • 開發平台分析

第3章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第4章 市場區隔

  • 全球結合型疫苗市場:各類型產品
    • 多價結合型疫苗
    • 單價結合型疫苗
  • 全球結合型疫苗市場:各疾病
    • 腦膜炎
    • 白喉·破傷風·百日咳
    • 流感
    • 肺炎
    • 其他
  • 全球結合型疫苗市場:患者類別
    • 成人
    • 兒童
  • 全球結合型疫苗市場:病原體類別
    • 面向細菌結合型疫苗
    • 面向病毒結合型疫苗
    • 混合疫苗

第5章 競爭環境

  • 主要策略分析
  • 主要企業分析

第6章 各地區分析

  • 北美市場 (美國,加拿大)
  • 歐洲市場 (英國,法國,德國,義大利,西班牙等)
  • 亞太地區市場 (印度,中國,日本等)
  • 其他的國家 (RoW)的市場

第7章 企業簡介

  • Astellas Pharma Inc.
  • ASTRAZENECA
  • BHARAT BIOTECH
  • BIOLOGICAL E LTD.
  • CSL BEHRING
  • GLAXOSMITHKLINE PLC.
  • 田邊三菱製藥
  • NOVARTIS AG
  • NEURON BIOTECH
  • MERCK & CO.
  • PFIZER
  • SERUM INSTITUTE OF INDIA PVT. LTD
  • SANOFI PASTEUR
目錄
Product Code: OMR2018306

The global conjugate vaccine market is anticipated to grow with the CAGR of 13.4% during the forecast period 2018-2023. Conjugate vaccines are similar to recombinant vaccines manufactured by the combination of two different components. Conjugate vaccines, however, are made by pieces from the coats of bacteria. These coats are chemically linked to a carrier protein, and the combination is used as a vaccine. Conjugate vaccines are used to create a more powerful, combined immune response from infectious diseases. The vaccines currently in use for children against pneumococcal bacterial infections are made using this technique. Haemophilus influenza type B (Hib) Vaccine, pneumococcal vaccine and meningococcal vaccine are some of the examples of conjugate vaccines.

The factors fuelling the growth of the conjugate vaccine market includes the increasing demand of meningococcal vaccines and pneumococcal. The increasing prevalence of infectious disease and rising awareness is estimated to boost the growth of the market. According to the U.S. National Library of Medicine, National Institutes of Health, the highest mortality cases reported were due to vaccine preventable diseases. High-income countries accounting for 87% of the population of have pneumococcal conjugate vaccines in their immunization schedules, whereas only 2% had pneumococcal conjugate vaccines in their immunization schedules among the total population of low-income countries.

The global conjugate vaccine market is segmented on the basis of product type, disease and pathogen type and patient type. On the basis of product type, the global conjugate vaccine market is bifurcated into multivalent conjugate vaccines and monovalent conjugate vaccines. The monovalent conjugate vaccines segment is one of the largest segment due to the high awareness and high-quality vaccines provided by key players. On the basis of disease, the global conjugate vaccine market can be segmented into meningococcal, diphtheria tetanus pertussis, influenza, pneumococcal, and others. On the basis of pathogen type, the global conjugate vaccine market segmented into combination conjugate vaccine, viral conjugate vaccine, and bacterial conjugate vaccine. On the basis of patient type, the market segmented into adult conjugate vaccine and pediatrics conjugate vaccine. The pediatrics conjugate vaccine segment has a potential market due to the high prevalence of infectious diseases among children.

Companies contributing to the growth of the global conjugate market include Serum Institute of India Pvt. Ltd., Sanofi Pasteur, Pfizer, Inc., Novartis AG, Neuron Biotech, Merck & Co., Inc., and GlaxoSmithKline plc. CSL Behring, Biological E, and Bharat Biotech and others.

The global conjugate vaccine market can be segmented geographically into, North America, Asia Pacific, Europe and rest of the world. North America is expected to be the most attractive market for conjugate vaccine during the forecast period, due to rise in demand for pneumococcal, meningococcal vaccines, and other conjugate vaccines. Asia Pacific is projected to increase during the forecast period owing to increasing immunization initiatives by organizations such as GAVI and World Health Organization in emerging economies such as India and China. Increasing focus of major players on the market in India and governmental initiatives for infectious diseases are likely to fuel the demand for the conjugate vaccines in the region.

Research Methodology

The market study of conjugate vaccines market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.
  • Supplier Websites such as Alibaba, amazon for pricing analysis.

The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

Market Segmentation

  • Global conjugate vaccine market by type
  • Global conjugate vaccine market by
  • Global conjugate vaccine market by immune response type
  • Global conjugate vaccine market by disease

THE REPORT COVERS:

  • Comprehensive research methodology of global conjugate vaccine market.
  • This report also includes detailed and extensive market overview with analyst insights & key market trends.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global conjugate vaccine market.
  • Insights about market determinants which are stimulating the global conjugate vaccine market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. REPORT SUMMARY

  • 1.1. RESEARCH METHODS AND TOOLS
  • 1.2. MARKET BREAKDOWN
    • 1.2.1. BY SEGMENTS
    • 1.2.2. BY GEOGRAPHY
    • 1.2.3. BY STAKEHOLDERS

2. MARKET OVERVIEW AND INSIGHTS

  • 2.1. DEFINITION
  • 2.2. ANALYST INSIGHTS &CURRENT MARKET TRENDS
    • 2.2.1. KEY FINDINGS
    • 2.2.2. RECOMMENDATION
    • 2.2.3. CONCLUSION
  • 2.3. REGULATIONS
    • 2.3.1. UNITED STATES
    • 2.3.2. EUROPEAN UNION
    • 2.3.3. CHINA
    • 2.3.4. INDIA
    • 2.3.5. REST OF THE WORLD
  • 2.4. PIPELINE ANALYSIS

3. MARKET DETERMINANT

  • 3.1. MOTIVATORS
    • 3.1.1. RISING PREVALENCE OF INFECTIOUS DISEASES
    • 3.1.2. INCREASING REGULATORY APPROVALS OF CONJUGATE VACCINES
    • 3.1.3. GOVERNMENT INITIATIVES TOWARDS DEVELOPMENT AND AWARENESS OF CONJUGATE VACCINES
    • 3.1.4. LONGER IMMUNITY AND BETTER SAFETY OF CONJUGATE VACCINES
  • 3.2. RESTRAINTS
    • 3.2.1. COMPLEX MANUFACTURING PROCESS
    • 3.2.2. LOW ACCESSIBILITY IN REMOTE AREAS
  • 3.3. OPPORTUNITIES
    • 3.3.1. RISING INVESTMENT IN DEVELOPING COUNTRIES
    • 3.3.2. RESEARCH AND DEVELOPMENT OF NEW VACCINES

4. MARKET SEGMENTATION

  • 4.1. GLOBAL CONJUGATE VACCINEMARKET BY PRODUCT TYPE
    • 4.1.1. MULTIVALENT CONJUGATE VACCINES
    • 4.1.2. MONOVALENT CONJUGATE VACCINES
  • 4.2. GLOBAL CONJUGATE VACCINE MARKET BY DISEASE
    • 4.2.1. MENINGOCOCCAL,
    • 4.2.2. DIPHTHERIA TETANUS PERTUSSIS,
    • 4.2.3. INFLUENZA,
    • 4.2.4. PNEUMOCOCCAL,
    • 4.2.5. OTHERS.
  • 4.3. GLOBAL CONJUGATE VACCINE MARKET BY PATIENT TYPE
    • 4.3.1. ADULTS
    • 4.3.2. CHILDREN
  • 4.4. GLOBAL CONJUGATE VACCINE MARKET BY PATHOGEN TYPE
    • 4.4.1. BACTERIAL CONJUGATE VACCINE
    • 4.4.2. VIRAL CONJUGATE VACCINE
    • 4.4.3. COMBINATION VACCINE

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGY ANALYSIS
  • 5.2. KEY COMPANY ANALYSIS

6. REGIONAL ANALYSIS

  • 6.1. NORTH AMERICA
    • 6.1.1. UNITED STATES
    • 6.1.2. CANADA
  • 6.2. EUROPE
    • 6.2.1. UNITED KINGDOM
    • 6.2.2. FRANCE
    • 6.2.3. GERMANY
    • 6.2.4. ITALY
    • 6.2.5. SPAIN
    • 6.2.6. REST OF EUROPE
  • 6.3. ASIA PACIFIC
    • 6.3.1. INDIA
    • 6.3.2. CHINA
    • 6.3.3. JAPAN
  • 6.4. REST OF THE WORLD

7. COMPANY PROFILES

  • 7.1. ASTELLAS PHARMA
  • 7.2. ASTRAZENECA
  • 7.3. BHARAT BIOTECH
  • 7.4. BIOLOGICAL E LTD.
  • 7.5. CSL BEHRING
  • 7.6. GLAXOSMITHKLINE PLC.
  • 7.7. MITSUBISHI TANABE PHARMA
  • 7.8. NOVARTIS AG
  • 7.9. NEURON BIOTECH
  • 7.10. MERCK & CO.
  • 7.11. PFIZER
  • 7.12. SERUM INSTITUTE OF INDIA PVT. LTD
  • 7.13. SANOFI PASTEUR

List of Tables

  • TABLE # 1: GLOBAL CONJUGATE VACCINE MARKET RESEARCH AND ANALYSIS, BY PRODUCT TYPE, 2017-2023,
  • TABLE # 2: GLOBAL MULTIVALENT CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLIONS)
  • TABLE # 3: GLOBAL MONOVALENT CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 4: GLOBAL CONJUGATE VACCINE MARKET RESEARCH AND ANALYSIS, BY DISEASE, 2017-2023, ($ MILLIONS)
  • TABLE # 5: GLOBAL MENINGOCOCCAL VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 6: GLOBAL DPT VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 7: GLOBAL INFLUENZA VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 8: GLOBAL PNEUMOCOCCAL VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 9: GLOBAL OTHER DISEASE VACCINE MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 10: GLOBAL CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATIENT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 11: GLOBAL ADULT CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 12: GLOBAL CHILDREN CNOJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 13: GLOBAL CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATHOGEN TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 14: GLOBAL BACTERIAL CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 15: GLOBAL VIRAL CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY 2017-2023, ($ MILLIONS)
  • TABLE # 16: GLOBAL COMBINATION CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLIONS)
  • TABLE # 17: NORTH AMERICAN CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PRODUCT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 18: NORTH AMERICAN CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY DISEASE TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 19: NORTH AMERICAN CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATIENT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 20: NORTH AMERICAN CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATHOGEN TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 21: EUROPEAN CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PRODUCT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 22: EUROPEAN CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY DISEASE TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 23: EUROPEAN CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATIENT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 24: EUROPEAN CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATHOGEN TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 25: APAC CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PRODUCT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 26: APAC CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY DISEASE TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 27: APAC CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATIENT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 28: APAC CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATHOGEN TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 29: ROW CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PRODUCT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 30: ROW CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY DISEASE TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 31: ROW CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATIENT TYPE 2017-2023, ($ MILLIONS)
  • TABLE # 32: ROW CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATHOGEN TYPE 2017-2023, ($ MILLIONS)

List of Figures

  • FIGURE # 1: GLOBAL CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PRODUCT TYPE 2017 VS 2023
  • FIGURE # 2: GLOBAL CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY DISEASE TYPE 2017 VS 2023
  • FIGURE # 3: GLOBAL CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATIENT TYPE 2017 VS 2023
  • FIGURE # 4: GLOBAL CONJUGATE VACCINES MARKET RESEARCH AND ANALYSIS, BY PATHOGEN TYPE 2017 VS 2023
  • FIGURE # 5: NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 6: US MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 7: CANADA MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 8: EUROPEAN MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 9: UK MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 10: FRANCE MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 11: GERMANY MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 12: ITALY MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 13: SPAIN MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 14: ROE MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 15: ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 16: INDIA MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 17: CHINA MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 18: JAPAN MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 19: ROAPAC MARKET RESEARCH AND ANALYSIS, 2017-2023
  • FIGURE # 20: REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2017-2023
Back to Top